BiVictriX Therapeutics Company
BiVictriX is a drug discovery and development company. Their services include oncology, haematological malignancies, bispecific ADC therapeutics, biotherapeutics, immunotherapy, antibody research, and drug development.
Last Funding Type:
Seed
Funding Status:
Seed
Headquarters:
Alderley Edge, Cheshire, United Kingdom
Founded Date:
2016
Last Funding Date:
08-19-2019
Employee Number:
1-10
Investors Number:
2
Industry:
PharmTech